Financials data is unavailable for this security.
View more
Year on year STAAR Surgical Co 's net income fell -46.18% from 39.67m to 21.35m despite revenues that grew 13.37% from 284.39m to 322.42m. An increase in the selling, general and administrative costs as a percentage of sales from 50.49% to 55.88% was a component in the falling net income despite rising revenues.
| Gross margin | 78.73% |
|---|---|
| Net profit margin | 6.38% |
| Operating margin | 7.53% |
| Return on assets | 4.32% |
|---|---|
| Return on equity | 5.40% |
| Return on investment | 4.92% |
More ▼
Cash flow in USDView more
In 2023, STAAR Surgical Co increased its cash reserves by 111.65%, or 96.56m. Cash Flow from Investing totalled 74.35m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 14.59m in cash from operations while cash generated from financing totalled 7.42m.
| Cash flow per share | 0.5597 |
|---|---|
| Price/Cash flow per share | 47.53 |
| Book value per share | 8.69 |
|---|---|
| Tangible book value per share | 8.65 |
More ▼
Balance sheet in USDView more
| Current ratio | 5.99 |
|---|---|
| Quick ratio | 5.38 |
| Total debt/total equity | 0.0002 |
|---|---|
| Total debt/total capital | 0.0002 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -46.23%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
| EPS growth(5 years) | 31.52 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 6.42 |
